# In vitro models of neurodegeneration

*Report generated: 2026-01-28 21:17:26*

**2 papers**

---

## Papers

### 1. RIG-I Mediated Neuron-Specific IFN Type 1 Signaling in FUS-ALS Induces Neurodegeneration and Offers New Biomarker-Driven Individualized Treatment Options for (FUS-)ALS.

**Authors:** Marcel Naumann, Theresa M Wierschin, Stefanie Kretschmer, Banaja P Dash, Aaron Held et al.

**Source:** pubmed | **Published:** 2026-Jan-28

**Link:** [https://pubmed.ncbi.nlm.nih.gov/41603250/](https://pubmed.ncbi.nlm.nih.gov/41603250/)

*Summary not available.*

### 2. Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodies

**Authors:** Carceles-Cordon, M.;  Brody, E.;  Boucher, M. L.;  Gallagher, M. D.;  Skrinak, R. T. et al.

**Source:** medrxiv | **Published:** 2026-01-28

**Link:** [https://www.medrxiv.org/content/10.64898/2026.01.26.26344888](https://www.medrxiv.org/content/10.64898/2026.01.26.26344888)

*Summary not available.*
